共 50 条
- [21] Pooled efficacy analysis of tradipitant in idiopathic and diabetic gastroparesis study VP-VLY-686-3301 and VP-VLY-686-2301 [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2023, 35
- [22] Pooled Efficacy Analysis of Tradipitant in Idiopathic and Diabetic Gastroparesis Study VP-VLY-686-3301 and VP-VLY-686-2301 [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S1133 - S1133
- [23] Not All Gastroparesis Is Gastroparesis [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S1247 - S1247
- [24] Tradipitant, a novel neurokinin-1 receptor antagonist, showed continued improvement in nausea and other symptoms associated with gastroparesis in an open-label extension of a phase II clinical trial [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2021, 33
- [25] Tradipitant, a Novel Neurokinin-1 Receptor Antagonist, Showed Continued Improvement in Nausea and Other Symptoms Associated with Gastroparesis in an Open-Label Extension of a Phase II Clinical Trial [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S651 - S651